CRISPR-Cas9 as a Tool for Drug Discovery
State of the Art Lecture
Transplantation TV goes in depth with Christof Fellmann, from Berkeley University’s Department of Molecular and Cell Biology, about what CRISPR-Cas9 is, what it can do, and why people should be paying attention to it.